角膜地形图引导激光消融联合快速角膜胶原交联治疗早期圆锥角膜的临床研究
前瞻性自身对照研究纳入19例(20眼)KC1~KC3级早期圆锥角膜患者,行地形图引导个性化LASEK联合快速CXL(0.1%核黄素浸泡10分钟,30 mW/cm²紫外线照射4分钟)。术后12个月最佳矫正视力无下降,50%眼提高3行及以上,柱镜度及角膜顶点曲率显著降低,角膜规则性改善,内皮细胞指标无显著变化。结论认为该联合治疗安全有效。
要点
- 术后12个月无最佳矫正视力丢失,50%眼提高3行及以上。
- 术后6和12个月柱镜度显著降低,角膜顶点曲率和平均瞳孔屈光力显著下降。
- 角膜最薄点厚度从术前461.9±31.1 μm降至术后416.6±27.0 μm,但角膜非对称性指数降低、规则性改善。
核心结论
- 角膜地形图引导个性化LASEK联合快速CXL治疗早期圆锥角膜安全有效,可阻止进展并改善角膜规则性,从而提高最佳矫正视力。
研究设计与样本
- 前瞻性自身对照研究,纳入2016年12月至2017年9月北京大学第三医院KC1~KC3级早期圆锥角膜患者19例20眼,年龄12至44岁(24.7±8.0岁),随访12个月以上。
主要发现
- 术后12个月无最佳矫正视力丢失,20%眼无改变、15%眼提高1行、15%眼提高2行、50%眼提高3行及以上。
- 术后6和12个月最佳矫正视力较术前提高(t=3.095,3.079;P<0.05),柱镜度降低(t=-2.890,-2.435;P<0.05)。
- 角膜顶点曲率(Z=-2.903,P<0.01)和4.5 mm瞳孔区平均屈光力(Z=-2.667,P<0.01)显著降低。
- 角膜最薄点厚度从术前(461.9±31.1)μm降至术后(416.6±27.0)μm(Z=-3.059,P<0.01),角膜前表面非对称性指数降低(Z=-2.667,P<0.01)。
- 术后12个月内皮细胞密度、六角形细胞百分比和细胞面积变异系数与术前差异无统计学意义(P>0.05)。
关键数值与推荐
- 圆锥角膜分级采用Amsler与Muckenhirn标准,纳入KC1~KC3级。
- 激光消融后以0.1%核黄素浸泡角膜基质床10分钟,再以30 mW/cm²紫外线照射4分钟。
- 术后12个月角膜上皮下雾状混浊0级、0.5级、1级、2级分别占20%、55%、20%、5%。
临床怎么用
- 对早期圆锥角膜(KC1~KC3)患者,可考虑地形图引导个性化LASEK联合快速CXL以改善角膜规则性和最佳矫正视力。
- 术后需随访角膜地形图、屈光度、最佳矫正视力及内皮细胞指标,并关注上皮下雾状混浊的发生。
局限性
- 研究为单中心前瞻性自身对照研究,样本量较小(19例20眼),缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the safety and efficacy of topography-guided customized excimer laser subepithelial ablation combined with accelerated collagen cross-linking technique in treatment of early keratoconus. Methods: Ninteen patients(20 eyes) (13 males 14 eyes, and 6 females 6 eyes), aged 12 to 44 years (24.7±8.0) were diagnosed as keratoconus by three-dimensional corneal topography and tomography, clinical history and examinations, and classified as KC1~KC3. Based on the classical excimer laser subepithelial keratomileusis (LASEK) method, topography guided laser ablation was performed with an excimer laser system (WaveLight EX500). After laser ablation, the corneal stromal bed was immersed with 0.1% riboflavin for 10 minutes, and then was irradiated by ultraviolet light (Avedro KXL) at 30 mW/cm(2) for 4 minutes. All the patients were followed up for more than 12 months. The uncorrected visual acuity (UCVA), diopter, best corrected visual acuity (BSCVA), corneal topography, central corneal endothelial cell density (ECD), hexagonal cell percentage (HEX), coefficient of variation (CV) and other indicators were observed. For normal distribution variables, Dunnett-t test was used before and after operation, and Wilcoxon test was used for variables with abnormal distribution. And the complications were recorded. Results: There was no loss of BSCVA at 12 months postoperatively, 20% of the eyes had no change of BSCVA, and 15% of the eyes gained 1 line of BSCVA, 15% of the eyes gained 2 lines of BSCVA, 50% of the eyes gained 3 lines and more of BSCVA. There was no significant difference in UCVA, BSCVA, manifest refractive spherical equivalent (MRSE) and the cylinder at 3 months postoperatively (P>0.05). The BSCVA were significantly improved at 6 and 12 months postoperatively compared with those before operation (t=3.095, 3.079, <0.05). Although there was no significant difference in UCVA and MRSE, the cylinder was significantly reduced at 6 and 12 months postoperatively (t=-2.890, -2.435, P<0.05). Apex curvature (Kapex) and mean pupil power (MPP) within 4.5mm of central cornea decreased significantly (Z=-2.903, P<0.01; Z=-2.667, P<0.01). Even though the thinnest corneal thickness decreased from pre-operational (461.9±31.1) μm to post-operational (416.6±27.0) μm (Z=-3.059, P<0.01), the cornea became regular with keratometric asymmetry index of anterior corneal surface decreased (Z=-2.667, P<0.01). The corneal optical quality parameters were improved. There was no significant difference in ECD, HEX and CV at 12 months postoperatively (P>0.05). Twelve months after operation, grade 0, 0.5, 1 and 2 haze were seen on 20%, 55%, 20% and 5% corneas respectively. Conclusions: The topography guided excimer laser ablation combined with accelerated corneal collagen cross linking is safe and effective in treatment of early stage keratoconus. It can significantly improve corneal regularity while preventing keratoconus progression, so as to improve the best corrected visual acuity postoperatively. (Chin J Ophthalmol, 2019, 55: 904-910). 目的: 探讨角膜地形图引导的个性化准分子激光角膜上皮瓣下磨镶术(LASEK)联合快速角膜胶原交联(CXL)治疗早期圆锥角膜的安全性及有效性。 方法: 前瞻性自身对照研究。纳入2016年12月至2017年9月在北京大学第三医院就诊并拟接受手术治疗的KC1~KC3级(Amsler与Muckenhirn标准)早期圆锥角膜患者进行研究。按经典的个性化LASEK方法,用角膜地形图引导的准分子激光进行个性化消融。激光消融完成后用0.1%核黄素浸泡角膜基质床10 min,以30 mW/cm(2)紫外线照射4 min。术后随访12个月以上,观察裸眼视力、屈光度、最佳矫正视力、角膜地形图、中央角膜内皮细胞密度(ECD)、六角形细胞百分比(HEX)和细胞面积变异系数(CV)等各项指标,记录并发症。对正态分布的变量手术前后变化采用Dunnett-t检验,对非正态分布的变量采用Wilcoxon检验。 结果: 本研究纳入早期圆锥角膜患者19例(20只眼),其中男性13例(14只眼),女性6例(6只眼);年龄(24.7±8.0)岁。术后12个月所有患眼最佳矫正视力相比术前未见降低;无改变、提高1行、提高2行、提高3行或以上者别为4只眼(20%)、3只眼(15%)、3只眼(15%)、10只眼(50%)。术后3个月裸眼视力、最佳矫正视力、等效球镜度数、柱镜度数与术前相比均差异无统计学意义(P>0.05)。术后6和12个月,最佳矫正视力与术前相比有所提高(t=3.095,3.079;P<0.05);柱镜度数降低(t=-2.890,-2.435;P<0.05);裸眼视力和等效球镜度数差异无统计学意义(P>0.05)。角膜顶点曲率显著降低(Z=-2.903,P<0.01);4.5 mm瞳孔对应范围内的角膜平均曲率显著降低(Z=-2.667,P<0.01);角膜最薄点厚度下降,从术前(461.9±31.1)mm降低至术后(416.6±27.0)μm(Z=-3.059,P<0.01);角膜变得规则:角膜前表面非对称性指数与术前相比显著降低(Z=-2.667,P<0.01);反映角膜光学质量的各项指数较术前改善。术前后ECD、HEX和CV差异均无统计学意义(P>0.05)。术后12个月,角膜上皮下雾状混浊0、0.5、1、2级者分别为4只眼(20%)、11只眼(55%)、4只眼(20%)、1只眼(5%)。 结论: 角膜地形图引导个性化LASEK联合快速CXL,对于早期圆锥角膜的治疗安全有效,可在阻止圆锥角膜进展的同时,显著改善角膜的规则性,以此提高患者术后的最佳矫正视力。(中华眼科杂志,2019,55:904-910).
引用
- Wang LC, Chen YG, Zhang Y, et al. [Clinical study on topography-guided laser ablation combined with accelerated corneal collagen cross-linking for early keratoconus]. Zhonghua Yan Ke Za Zhi. 2019. PMID: 31874503. doi:10.3760/cma.j.issn.0412-4081.2019.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。